A detailed history of Alpha Paradigm Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 4,641 shares of JNJ stock, worth $771,102. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,641
Holding current value
$771,102
% of portfolio
0.34%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $743,488 - $834,405
4,641 New
4,641 $819,000
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $1.96 Million - $2.17 Million
11,656 New
11,656 $2.07 Billion
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $344,745 - $391,506
-2,180 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $1.34 Million - $1.49 Million
-8,585 Reduced 79.75%
2,180 $373 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $1.69 Million - $1.88 Million
10,482 Added 3703.89%
10,765 $1.74 Billion
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $45,132 - $48,412
283 New
283 $47 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.